Maria Sjöberg
Plus aucun poste en cours
Profil
Maria Sjöberg worked as CEO, CSO, and VP-Preclinical Research & Development at Karo Healthcare AB in 2015.
She also worked as Director-Production and Head-Research & Development at SentoClone AB from 2009 to 2012.
Anciens postes connus de Maria Sjöberg
| Sociétés | Poste | Fin |
|---|---|---|
SentoClone AB
 SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Directeur Technique/Scientifique/R&D | 31/12/2012 |
| KARO PHARMA AB (PUBL) | Directeur Général | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KARO PHARMA AB (PUBL) | Health Technology |
| Entreprise privées | 1 |
|---|---|
SentoClone AB
SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Commercial Services |
